Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy

Acta Oncologica

Volumn 45, Issue 6, 2006, Pages 695-701

  Serkies, Krystyna ^a   Badzio, Andrzej ^a   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; ANALYSIS OF VARIANCE; ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLAND; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33748643427     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600833160     Document Type: Article

References (30)

1. Mercadante S, Gebbia V, Marazzo A, Filosto S. Anemia in cancer: Pathophysiology and treatment. Cancer Treat Rev 2000;26:303-11.
2. Dusenberg KE, McGuire WA, Holt PJ, et al. Erythropoetin increases hemoglobin during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 1994;29:1079-84.
3. Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anemia, hypoxia and transfusion in patients with cervical cancer: A review. Radiother Oncol 2000;57:13-9.
4. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer. Cancer 2001;91:2214-21.
5. Chatani M, Matayoshi Y, Masaki N, Inoue T. High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. Strahlenther Onkol 1999;173:379-84.
6. Dunst J, Kuhnt T, Strauss HG, et al. Anemia in cervical cancers; impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-87.
7. Fyles AW, Pintile M, Kirkbride P, Levin W, Manchul LA, Rawlings GA. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of a multiple regression analysis. Radiother Oncol 1995;35:107-17.
8. Gasinska A, Urbanski K, Adamczyk A, Pudelek J, Lind BK, Brahme A. Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncol 2002;41:437-43.
9. Girinski T, Pejovic-Lenfant MH, Bouhis J, et al. Prognostic value of hemoglobin concentration and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989;16:37-42.
10. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
11. Hsu H-CH, Leung SW, Huang E-Y, et al. Impact of the extent of parametrial involvement in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:405-10.
12. Kapp DS, Fisher D, Gutierrez E, Kohorn IE, Schwartz PE. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariate analysis of the effect of age, stage, histology, and blood counts on survival. Int J Radiat Oncol Biol Phys 1983;9:445-55.
13. Karolewski K, Korzeniowski S, Sokolowski A, Urbanski K, Kojs Z. Prognostic significance of pretherapeutic and therapeutic factors in patients with advanced cancer of the uterine cervix treated with radical radiotherapy. Acta Oncol 1999;38:461-8.
14. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999;43:763-75.
15. Pedersen D, Sogaard H, Overgaard J, Bentzen SM. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the cervix treated by radiotherapy alone. Acta Oncol 1995;34:787-95.
16. Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc JH. Prognostic factors for local and distant recurrence in Stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1309-17.
17. Vigario G, Kurohara SS, George FW. Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer. Radiology 1973;106:649-52.
18. Yalman D, Aras AB, Ozkok S, et al. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Eur J Gynecol Oncol 2003;3:309-14.
19. MacRac R, Shyr Y, Johnson D, Choy H. Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant. Radiother Oncol 2002;64:37-40.
20. Rofstad EK, Sunfor K, Lyng H, Trope CG. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastases. Br J Cancer 2000;83:354-9.
21. Vaupel P, Thews O, Mayer A, Hockel S, Hockel M. Oxygenation status of gynecologic tumors: What is the optimal hemoglonim level? Strahlenther Onkol 2002;178:727-31.
22. Fyles BA, Milosevic M, Hedley D, et al. Tumor hypoxia has independent predictor impact only in patients with nodenegative cervix cancer. J Clin Oncol 2002;20:680-7.
23. Sundfor K, Lyng H, Kongsgard UL, Trope C, Rofstad EK. Polarographic measurement of pO2 in cervix carcinoma. Gynecol Oncol 1997;64:230-6.
24. Santin AD, Bellone S, Parrish RS, et al. Influence of allogenic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest 2003;56:28-34.
25. Larsson A-M, Landberg G, Pahlman S, Albertsson M. Erythropoietin enhances response to treatment in patients with advanced breast cancer. Acta Oncol 2004;43:594-7.
26. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet;362:1255-60.
27. Leyland-Jones B, Semiglazov V, Pawlicki M, et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study. J Clin Oncol 2005; 23:5960-72.
28. Kirwan JM, Symonds P, Creen JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217-26.
29. Van Belle S J-P, Cocquyt V. Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol/Hematol 2003;47:1-11.
30. Obermair A, Cheuk R, Horwood K, et al. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival. Int J Gynecol Cancer 2003;13:633-9.